Prophylactic Antibiotic Use in Patients with Rheumatic Diseases
Patients with RA who undergo total hip or knee replacement are at increased risk for prosthetic joint infection, which is further increased in the setting of revision arthroplasty and a previous prosthetic joint infection “as reported by Poss et al. (Clin Orthop 182:117–126, 1984) and Bongartz et al. (Arthritis Rheum. 59(12):1713–20, 2008).” Perioperative prophylactic measures and vigilance during the postoperative period are important in assuring good outcomes in such patients.
KeywordsProphylactic antibiotics Iatrogenic infection Septic arthritis
- 8.Gilson M, Gossec L, Mariette X, Gherissi D, Guyot MH, Berthelot JM, Wendling D, Michelet C, Dellamonica P, Tubach F, Dougados M, Salmon D. Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study. Arthritis Res Ther. 2010;12(4): R145.PubMedCrossRefGoogle Scholar
- 10.den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, de Waal-Malefijt M, van den Hoogen FH. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol. 2007;34(4):689–95.Google Scholar
- 11.Momohara S, Kawakami K, Iwamoto T, Yano K, Sakuma Y, Hiroshima R, Imamura H, Masuda I, Tokita A, Ikari K. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol. 2011;21(5):469–75.PubMedCrossRefGoogle Scholar
- 12.Solomon DH, Losina E, Baron JA, Fossel AH, Guadagnoli E, Lingard EA, Miner A, Phillips CB, Katz JN. Contribution of hospital characteristics to the volume-outcome relationship: dislocation and infection following total hip replacement surgery. Arthritis Rheum. 2002;46(9):2436–44.PubMedCrossRefGoogle Scholar
- 13.Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736–54.PubMedCrossRefGoogle Scholar
- 14.Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. American Heart Association Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. American Heart Association. J Am Dent Assoc. 2008;139(Suppl):3S–24.PubMedGoogle Scholar
- 16.American Academy of Orthopaedic Surgeons (AAOS). Advisory Statement. Recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty 2004. http://www.aaos.org/about/papers/advistmt/1027.asp. Accessed 2 Mar, 2011.
- 17.Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2006; 4:83.Google Scholar
- 21.American Dental Association; American Academy of Orthopedic Surgeons. Antibiotic prophylaxis for dental patients with total joint replacements. J Am Dent Assoc. 2003;134:895–8.Google Scholar
- 22.American Academy of Orthopedic Surgeons. Information statement: prophylaxis for bacteremia in patients with joint replacements. http://www.aaos.org/about/papers/advistmt/1033.asp. Accessed 2 Mar, 2011.